Splice Bio
Barcelona, ES · 4 known investors
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes. The company is currently in clinical stages, with its lead program targeting Stargardt Disease.
Founders & leadership
DV
Dr. Vila-PerellóCEO
DF
Dr. FrutosCo-founder